Class / Patent application number | Description | Number of patent applications / Date published |
424666000 | Hydrochloric acid | 9 |
20080206359 | Day and Night Composition and method for treating Pseudofolliculitis Barbae - An effective formulation for the treatment and prevention of pseudofolliculitis barbae, commonly called razor bumps, and the skin irritation associated with the condition. The treat formulation can be used as the last step in a multi-step shaving system consisting of a shaving gel, aftershave balm and the aforementioned treat. The treat can also be used as a standalone product and is formulated to treat and prevent shaving symptoms day and night. | 08-28-2008 |
20080317871 | Use of Hydrochloric Acid For the Manufacture of a Medicament For the Treatment of Hypertension - A method of treating hypertension by administering to a patient an aqueous solution of HCl having a pH from 3 to 6.9 for a period of from 0.5 to 6 years and a method of treating a calculus disease by administering an aqueous solution of HCl having a pH from 3 to 6.9 are disclosed. | 12-25-2008 |
20090123568 | KIT USEFUL FOR TREATING TUMORS AND LESIONS OF THE SKIN AND THE MUCOUS MEMBRANES - The pharmaceutical preparation useful for treating a skin or mucous membrane lesion is provided. The pharmaceutical preparation including, as active ingredients, a therapeutically effective amount of trichloroacetic acid and hydrochloric acid, or trichloroacetic acid and formic acid or all three of these acids and optionally a crosslinking/fixating/preserving agent. Additional preparations are also described. | 05-14-2009 |
20100055204 | USE OF HYDROCHLORIC ACID IN THE MANUFACTURE OF MEDICAMENT FOR TREATING DISEASE CAUSED BY FOULING OF TRANSPORT TRACT - Use of hydrochloric acid in the manufacture of a medicament for treating the disease caused by fouling of transport tract, wherein the disease comprises diabetes and prostate disease. | 03-04-2010 |
20120034319 | ANTIMICROBIAL HYDROCHLORIC ACID CATHETER LOCK SOLUTION AND METHOD OF USE - A catheter lock solution includes a hydrochloric acid solution having a concentration of 0.3 Molar to 1.0 Molar. This hydrochloric acid solution may be used to lock a catheter and/or salvage an infected catheter. | 02-09-2012 |
20120093945 | METHOD FOR TREATING AN INFLAMMATION OR LESION CAUSED BY A VIRUS - A method for treating an inflammation or lesion caused by herpes virus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C | 04-19-2012 |
20120128795 | COLORLESS, NON-FUMING, HAZARDLESS AND STABLE AQUA-REGIA, ITS PREPARATION METHOD AND USE IN TREATING MEDICAL DISORDERS - A method for production of colorless, non-fuming, hazardless and stable aqua-regia solution is provided. The method includes heating a dry mixture of potassium nitrate, potassium chloride and potassium aluminum sulphate to obtain vapors of aqua-regia and condensing the vapors obtained to form a colorless, non-fuming, hazardless and stable aqua-regia solution. The method produces aqua-regia directly from dry salts without adding any single drop of solvent. Aqua-regia obtained by this method is highly stable and possesses dual property of being an anti-diarrheal as well as a rehydrating compound. | 05-24-2012 |
20120315341 | METHOD FOR TREATING AN INFLAMMATION OR LESION CAUSED BY A VIRUS - A method for treating an inflammation or lesion caused by herpes virus, comprising topically applying to said inflammation or lesion a composition comprising or consisting essentially of a C | 12-13-2012 |
20150030702 | NITRIC OXIDE-GENERATING SKIN DRESSINGS - A skin dressing is provided comprising a first component including a source of protons, a second component including a nitrite salt, the skin dressing further comprising a non-thiol reductant. The skin dressing is adapted, such that, when the first and second components are brought together and applied to a skin site the nitrite reacts to generate nitric oxide, increasing the pH of the dressing in contact with the skin site from an acidic value to a more neutral value. | 01-29-2015 |